Sarcoma  >>  TAEST16001  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
TAEST16001 / Guangzhou Xiangxue Pharma, Athenex
ChiCTR2000031226: An open, single arm and early clinical study of TAEST16001 in the treatment of solid tumor mainly containing soft tissue sarcoma with positive expression of tumor antigen NY-ESO-1 (HLA-A * 02:01)

Recruiting
N/A
12
 
TAEST16001 cells treat tumor antigen NY-ESO-1
Sun Yat-Sen University Cancer center; Sun Yat-Sen University Cancer Center, Guangdong Xiangxue Precision Medical Technology Co., Ltd.
soft tissue sarcoma
 
 

Download Options